000 | 01800 a2200601 4500 | ||
---|---|---|---|
005 | 20250516133931.0 | ||
264 | 0 | _c20131017 | |
008 | 201310s 0 0 eng d | ||
022 | _a1665-2681 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLadero, José M | |
245 | 0 | 0 |
_aVitamin D deficiency and vitamin D therapy in chronic hepatitis C. _h[electronic resource] |
260 |
_bAnnals of hepatology _c |
||
300 |
_a199-204 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 | _aChi-Square Distribution |
650 | 0 | 4 | _aCross-Sectional Studies |
650 | 0 | 4 | _aDietary Supplements |
650 | 0 | 4 | _aElasticity Imaging Techniques |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHepacivirus _xgenetics |
650 | 0 | 4 |
_aHepatitis C, Chronic _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 | _aInterferons |
650 | 0 | 4 |
_aInterleukins _xgenetics |
650 | 0 | 4 |
_aLiver Cirrhosis _xdiagnosis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aOdds Ratio |
650 | 0 | 4 | _aPolymorphism, Genetic |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 |
_aRNA, Viral _xblood |
650 | 0 | 4 |
_aSpain _xepidemiology |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVitamin D _xanalogs & derivatives |
650 | 0 | 4 |
_aVitamin D Deficiency _xblood |
650 | 0 | 4 |
_aVitamins _xtherapeutic use |
700 | 1 | _aTorrejón, María J | |
700 | 1 | _aSánchez-Pobre, Pilar | |
700 | 1 | _aSuárez, Avelina | |
700 | 1 | _aCuenca, Francisca | |
700 | 1 | _ade la Orden, Virginia | |
700 | 1 | _aDevesa, María J | |
700 | 1 | _aRodrigo, María | |
700 | 1 | _aEstrada, Vicente | |
700 | 1 | _aLópez-Alonso, Gustavo | |
700 | 1 | _aAgúndez, José A | |
773 | 0 |
_tAnnals of hepatology _gvol. 12 _gno. 2 _gp. 199-204 |
|
999 |
_c22492106 _d22492106 |